Balance Sheet Components

12 Months Ended

Dec. 31, 2022

Balance Sheet Components

Balance Sheet Components

7. Balance Sheet Components (in thousands):

	December 31,		December 31,
	2022		2021
Prepaid and Other Current Assets
Interest receivable	$	45	$	32
Prepaid research and development manufacturing expenses		192		740
Prepaid facility expenses		182		174
Prepaid insurance		252		280
Other		102		128
	$	773	$	1,354
Property and Equipment
Laboratory equipment	$	2,673	$	2,477
Computer equipment and purchased software		142		142
Leasehold improvements		2,084		2,084
		4,899		4,703
Less: accumulated depreciation and amortization		(4,546)		(4,252)
	$	353	$	451
Accrued and Other Liabilities
Accrued clinical trial expense	$	2,934	$	4,010
Accrued manufacturing expense		3,254		839
Personnel related		1,113		1,846
Accrued legal and accounting		89		265
Other		158		121
	$	7,548	$	7,081

During the years ended December 31, 2022, 2021, and 2020, the Company recorded $0.4 million, $0.5 million and $0.6 million in depreciation expense, respectively.